Heparin-induced thrombocytopenia;Thrombopenies induites par l'heparine

Annales de Biologie Clinique

Volumn 58, Issue 3, 2000, Pages 317-326

  Depasse, F ^a   Samama, M M ^a  

^a Laboratoire Claude Levy   (France)

Author keywords

Heparin induced thrombocytopenia

Indexed keywords

ALPHA INTERFERON; AMINOGLUTETHIMIDE; AMIODARONE; AMPHOTERICIN B; ANTICOAGULANT AGENT; AUTOANTIBODY; CHLOROTHIAZIDE; CHONDROITIN SULFATE; CIMETIDINE; COTRIMOXAZOLE; DANAPAROID; DANAZOL; DERMATAN SULFATE; DICLOFENAC; DIGOXIN; DRUG DERIVATIVE; ETHAMBUTOL; HEPARAN SULFATE; HEPARIN; HIRUDIN; LEPIRUDIN; LEVAMISOLE; METHYLDOPA; NALIDIXIC ACID; OXPRENOLOL; QUINIDINE; QUININE; RECOMBINANT PROTEIN; RIFAMPICIN; SALAZOSULFAPYRIDINE; SULFAFURAZOLE; THROMBOCYTE FACTOR 4; VANCOMYCIN; HIRUDIN DERIVATIVE;

ALLERGIC REACTION; ANTIBODY PRODUCTION; ANTICOAGULANT THERAPY; AUTOIMMUNITY; CLINICAL FEATURE; DIAGNOSTIC TEST; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IATROGENIC DISEASE; IMMUNOLOGY; PATHOPHYSIOLOGY; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; THROMBOEMBOLISM; CHEMICALLY INDUCED DISORDER;

ANTIBODY FORMATION; ANTICOAGULANTS; CHONDROITIN SULFATES; DERMATAN SULFATE; HEPARIN; HEPARITIN SULFATE; HIRUDIN THERAPY; HIRUDINS; HUMANS; RECOMBINANT PROTEINS; THROMBOCYTOPENIA;

EID: 0034131352     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Wallis DE, Lewis BE, Messmore H, Wehrmacher WH. Heparin-induced thrombocytopenia and thrombosis syndrom. Clin Appl Thrombosis/Haemomasis 1998 ; 4 : 160-3.
2. Arnoux D, Boutière B, Sampol J. Thrombopénies induites par l'héparine. Spectra Biologie 1994 ; 94/3 : 35-8.
3. Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia : towards consensus. Thromb Haemost 1998 ; 79 : 1-7.
4. Hirsh J, Warkentin TE, Raschke R, Granger C, Magnus Ohman E, Dalen J. Heparin and low-molecular-weight heparin : mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy and safety. Chest 1998 ; 114 : 489S-510S.
5. Amiral J, Wolf M, Vissac AM, Meyer D. Mécanismes moléculaires et cellulaires des thrombopénies induites par l'héparine. Hématologie 1996; 2 : 279-86.
6. Warkentin TE. Heparin-induced thrombocytopenia : a clinicopathologic syndrome. Thromb Haemost 1999 ; 82 : 439-47.
7. Amiral J, Bridey F, Dreyfus M, Vissac AM, Fressinaud E, Wolf M, Meyer D. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 1992 ; 68: 95-6.
8. Warkentin TE. Heparin-induced thrombocytopenia : pathogenesis, frequency, avoidance and management. Drug Safety 1997 ; 17 : 325-41.
9. Warkentin TE, Barkin RL. Newer strategies for the treatment of heparin induced thrombocytopenia. Pharmacotherapy 1999 ; 19 : 181-95.
10. Bachelot-Loza C, Safrroy R, Lasne D, Chatellier G, Aiach M, Rendu F. Importance of the FcgRIIa-Arg/His-131 polymorphism in heparin-induced thrombocytopenia diagnosis. Thromb Haemost 1998 ; 79 : 523-8.
11. Visentin GP. Heparin-induced thrombocytopenia : molecular pathogenesis. Thromb Haemost 1999 ; 82 : 448-56.
12. McDonald K, Horne I, Alkins BR. Platelet binding of IgG from patients with heparin induced thrombocytopenia. J Lab Clin Med 1996 ; 127 : 435-42.
13. Amiral J. Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin induced thrombocytopenia. Br J Haematol 1996 ; 92 : 954-9.
14. Amiral J. Presence of antibodies to interleukine-8 or neutrophil-activating peptide-2 in patients with heparin associated thrombocytopenia. Blood 1996 ; 88 : 410-6.
15. Chong B. Heparin-induced thrombocytopenia. Br J Haematol 1995 ; 89 : 431-9.
16. Warkentin TE, Kelton JG. Interaction of heparin with platelets, including heparin induced thrombocytopenia. In : Bounameaux H. Low molecular weight heparins in prophylaxis and therapy of thromboembolic diseases. New York, Dekker, 1994 : 75-127.
17. Warkentin TE. Clinical presentation of heparin induced thrombocytopenia. Semin Haematol 1998 ; 35 : 9-16.
18. Elalamy I, Potevin F, Lecrubier C, Bara L, Marie JP, Samama MM. A fatal low-molecular-weight-heparin-associated thrombocytopenia after hip surgery : possible usefulness of PF4-heparin Elisa test. Blood Coagulation and Fibrinolysis 1996 ; 7 : 665-71.
19. Warkentin TE. Heparin induced thrombocytopenia : a ten year retrospective. Annu Rev Med 1999 ; 50 : 129-47.
20. Gardyn J, Sorkin P, Kluger Y, et al. Heparin induced thrombocytopenia and fatal thrombosis in a patient with activated protein C resistance. Am J Haematol 1995 ; 50 : 292-5.
21. George JN, Raskob GE, Rizvi Sha S, et al. Drug-induced thrombocytopenia : a systematic review of published case reports. Ann Intern Med 1998 ; 129 : 886-90.
22. Elalamy I, Potevin F, Lecrubier C, Amiral J, Marie JP, Samama MM. Diagnostic biologique de la thrombopénie immunoallergique à l'héparine (TIH) : comparaison des tests d'agrégation plaquettaire et Elisa « facteur 4 plaquettaire-héparine » (HPIA) chez 100 patients. Feuillets de Biologie 1998 ; 39 : 9-16.
23. Eichler P, Budde U, Haas S, et al. First workshop for detection of heparin-induced antibodies : validation of the heparin-induced platelet-activation test (Hipa) in comparison with a PF4/heparin Elisa. Thromb Haemost 1999 ; 81 : 625-9.
24. Tomer A, Masalunga C, Abshire TC. Determination of heparin induced thrombocytopenia : a rapid flow cytometric assay for direct demonstration of antibody mediated platelet activation. Am J Haematol 1999 ; 61 : 53-61.
25. Walenga JM, Jeske WP, Fasanella AR, Wood JJ, Bakhos M. Laboratory tests for the diagnosis of heparin induced throbocytopenia. Semin Thromb Haemost 1999 ; 25 (suppl. 1) : 43-9.
26. Newman PM, Swanson RL, Chong BH, Heparin-induced thrombocytopenia : IgG binding to PF4-heparin complexes in the fluid phase and cross-reactivity with low molecular weight heparin and heparinoid. Thromb Haemost 1998 ; 80 : 292-7.
27. Meyer O, Salama A, Pittet N, Schwind P. Rapid detection of heparin-induced platelet antibodies with particle gel immunoassay (ID-HPF4). Lancet 1999 ; 354 : 1525-6.
28. Bauer TL, Arepally G, Konkle B, et al. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation 1997 ; 95 : 1242-6.
29. Trossaert M, Gaillard A, Commin PL, Amiral J, Vissac AM, Fressinaud E. High incidence of anti-heparin/platelet factor 4 antibodies after cardiopulmonary bypass surgery. Br J Haematol 1998 ; 101 : 653-5.
30. Lecompte T, Stieltjes N, Shao-kai L, Morel M, Kaplan C, Samama MM. Heparin and streptokinase-dependent platelet activating immunoglobulin G : mechanism and diagnosis. Semin Thromb Haemost 1995; 21 : 95-105.
31. Pouplard C, Amiral J, Borg JY, Vissac AM, Delahousse B, Gruel Y. Differences in specificity of heparin-dependent antibodies developped in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodium. Br J Haematol 1997 ; 99 : 273-80.
32. Greinacher A, Treatment of heparin-induced thrombocytemia. Thromm Haemost 1999 ; 82 : 457-67.
33. Tardy-Poncet B, Reynaud J, Tardy B, et al. Thrombopénie induite par l'héparine : traitement par l'ORG 10172. Presse Med 1996 ; 25 : 751-5.
34. Elalamy I, Lecrubier C, Potevin F, et al. Absence of in vitro cross-reaction of pentasaccharide with the plasma heparin dependent factor of twenty-five patients with heparin-associated thrombocytopenia. Thromb Haemost 1995 ; 74 : 1379-87.
35. Corbeau JJ, Jacob JP, Moreau X, Cottineau C, De Brux JL, Delhumeau A. Ioprost (Iloméine®) et circulation extracorporelle avec héarinisation conventionnelle chez un patient ayant une thrombopénie induite par l'héparine. Ann Fr Anesth Réanim 1993 ; 12 : 55-9.
36. Grant SM, Goa KL, Iloprost : a review of its pharmacodynamic properties and therapeutic potential in preipheral vascular disease, myocardial ischemia and extra-corporeal circulation procedures. Drugs 1992 ; 43 : 889-924.
37. Kappa JR, Fisher CA, Todd B, et al. Intraoperative management of patients with heparin-induced thrombocytopenia. Ann Thorac Surg 1990 ; 49 : 714-23.
38. Herbert JM, Savi P, Jeske WP, Walenga JM. Effect of SR121566A, a potent GP IIb-IIIa antagonist, on the HIT serum/heparin-induced platelet mediated activation of human endothelial cells. Thromb Haemost 1998 ; 80 : 326-31.